NeuroDerm Announces Highly Positive Results from the Pivotal

ND0612, a continuous 24 hours/day subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD), showed superior efficacy compared to oral LD/CD for the...

Related Keywords

Rehovot , Hamerkaz , Israel , Osaka , Japan , United States , America , American , C Warren Olanow , Enola Chen , Mitsubishi Chemical Group , Neuroderm Ltd , Mitsubishi Tanabe Pharma America Inc , American Academy Of Neurology Annual Meeting , Mitsubishi Tanabe Pharma Corporation , Medicine Committee International Parkinson , Movement Disorder Society Evidence , Prnewswire Neuroderm Ltd , Parkinson Foundation , Michaelj Fox Foundation , Mitsubishi Tanabe Pharma Holdings America Inc , Unified Parkinson , Disease Rating Scale Part , Patient Global Impression , Clinical Global Impression , Derm Ltd , About Parkinson , Mitsubishi Chemical , Tanabe Pharma Corporation , Mitsubishi Tanabe Pharma America , Jersey City , Mitsubishi Tanabe Pharma Holdings America , Neural Transm , Choice Between Advanced Therapies , Disease Patients , Tolerability Study , Motor Fluctuations , American Academy , Neurology Annual Meeting , Who Has Parkinson , Rev Dis , Drug Insight , Nat Rev Neurol ,